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S U M M A R Y
Two typical symptoms of severe fever with thrombocytopenia syndrome (SFTS) are fever and
thrombocytopenia. Here we report a laboratory conﬁrmed SFTS case with no fever during the entire
hospitalization period, in Daishan County, Zhejiang Province, China. A 77-year-old woman was admitted
to hospital with symptoms including nausea, retching, and anorexia. Laboratory tests revealed
thrombocytopenia, leukopenia, and liver and brain damage. The case was later conﬁrmed as a novel
bunyavirus infection. Epidemiological investigations revealed that she had no history of tick bites or skin
damage, and no known exposure to persons with a similar illness in the area prior to illness onset. The
patient was hospitalized for 15 days, and during the whole admission period, she did not experience any
fever. The patient recovered and was discharged.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-
nc-sa/4.0/).
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Severe fever with thrombocytopenia syndrome (SFTS) is a
newly identiﬁed infectious disease caused by a novel bunyavirus.
Severe fever with thrombocytopenia syndrome virus (SFTSV) was
ﬁrst isolated from a patient in China in 2010.1 Recent surveillance
data have shown that seven provinces in northeastern and central
China, including Henan, Hubei, Shandong, Anhui, Jiangsu, Liaoning,
and Zhejiang, are major endemic areas of SFTS. Moreover, SFTS
cases have been reported in Japan and South Korea.
The main clinical symptoms and laboratory ﬁndings in most
hospitalized patients include fever, thrombocytopenia, gastroin-
testinal symptoms, hemorrhagic manifestations, myalgia, dizzi-
ness, leukopenia, abnormal coagulation times, and elevated serum
hepatic enzymes. The reported case fatality rate is up to 12–15%.2
Ticks are the supposed vectors of SFTSV infections in humans.3
Furthermore, it has been reported that the disease can be* Corresponding authors. Tel.: +86 571 87115009; fax: +86 571 87115100.
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1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-sa/4.0/).transmitted from person to person through direct contact with
the blood or mucous of an SFTS patient.4,5
Since the ﬁrst SFTS case in Zhejiang was diagnosed in November
2011, a total 115 similar cases together with 17 deaths had
occurred by August 2014, with a case fatality rate of 14.8%. Daishan
County, an island county of Zhejiang, has been classiﬁed as an area
endemic for SFTS. As of April 2014, a total of 57 SFTS cases and eight
deaths had been reported in this county; the reported case fatality
rate was 14.0%. Here, we report a special case of SFTS diagnosed on
October 27, 2013 in Daishan County.
2. Case report
On October 20, 2013, a 77-year-old woman developed
symptoms of paroxysmal vertigo, accompanied by nausea,
retching, and anorexia. She did not take any medical treatment,
and ﬁve days later she visited an outpatient clinic. With a
preliminary diagnosis of vertigo and cerebral circulation insufﬁ-
ciency, she was admitted to the First People’s Hospital of Daishan.
The physical examination upon admission revealed a temperature
of 36.5 8C, pulse of 62 beats/min, respiration rate of 18/min, and
blood pressure of 117/64 mmHg. Swollen lymph nodes were
palpable in the inguinal regions. No petechiae or ecchymosis wasciety for Infectious Diseases. This is an open access article under the CC BY-NC-SA
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tests were negative. Laboratory tests indicated thrombocytopenia,
leukopenia, and increased aspartate aminotransferase (AST),
lactate dehydrogenase (LDH), creatine kinase (CK), and blood urea
nitrogen (BUN). Based on the empirical treatment of leukopenia,
leucogen and adenine phosphate were administered. Meanwhile,
betahistine, salviol, and vinpocetine were prescribed to improve
cerebral circulation.
On the 6th day, the patient’s platelet and neutrophil counts
decreased to 59  109/l and 0.4  109/l, respectively. Computed
tomography (CT) scans of the brain and cervical vertebrae showed
ischemic white matter degeneration adjacent to the lateral
cerebral ventricles, encephalomalacia in the left frontal temporal
region, brain atrophy, and cervical vertebra hyperosteogeny.
Abdominal ultrasound imaging demonstrated two single hepatic
cysts, with the larger one measuring 9 mm by 7 mm in size. Atrial
ﬁbrillation and a complete right bundle branch block were
revealed on her electrocardiogram (ECG). Although she did not
present a persistent fever, all signs and symptoms suggested that
the patient had an SFTSV infection. Intravenous compound
glycyrrhizin was prescribed to protect the liver and lower
transaminase levels. Hypodermic injection of recombinant human
granulocyte colony stimulating factor (GM-CSF; 75 mg) was done
to increase the white blood cell level, along with supportive and
symptomatic treatments.
On the 7th day, a serum specimen was collected from the
patient; SFTSV infection was conﬁrmed by reverse transcription
PCR. The betahistine, salviol, and vinpocetine were therefore
stopped, and ribavirin and qingkailing dispersible tablets were
added (qingkailing is a Chinese medicine brand, made from herbal
ingredients such as jasmine, mainly used to alleviate the
symptoms of heat, intoxication, and nervousness). Platelet and
plasma transfusions were given when necessary. The patient began
to recover during the following days. Clinical ﬁndings are
summarized in Table 1.
On the 20th day, the patient was discharged at the request of her
and her family. The doctor suggested continued use of oral drugs
and subsequent clinical visits because she still presented
leukopenia. Further examinations revealed that the patient had
recovered on the 33rd day. Meanwhile, the patient’s sample tested
positive for IgG-speciﬁc antibodies to SFTSV by indirect immuno-
ﬂuorescence assay (IFA), further corroborating the previous
diagnosis of SFTSV infection. Subsequently, SFTSV was isolated
from the acute phase serum. Virus culture and gene sequencing
were performed. L, S, and M segment sequencing and analysisTable 1
Laboratory ﬁndings of the presented case of severe fever with thrombocytopenia synd
Laboratory ﬁndings Days after illness onset 
5 (Oct 25) 6 (Oct 26) 8 (Oct 28) 
WBC (109/l) 1.3 1.4 3.2 
Neutrophils (109/l) 0.5 0.4 1.9 
Lymphocytes (109/l) 0.7 0.7 0.9 
Platelets (109/l) 74 59 63 
Red cell count (1012/l) 4.71 4.09 3.62 
Hemoglobin (g/l) 149 126 113 
ALT (U/l) - 218 - 
AST (U/l) 469 414 293 
LDH (U/l) 509 - 297 
CK (U/l) 234 - 81 
CK-MB (U/l) 34 - 19 
Creatinine (m mol/l) 102 97 76 
BUN (mmol/l) 12.0 9.7 3.8 
TT (s) 20.2 - 21.1 
PT (s) 11.2 - 11.4 
APTT (s) 35.0 - 26.3 
WBC, white blood cells; ALT, alanine aminotransferase; AST, aspartate aminotransferas
thrombin time; PT, prothrombin time; APTT, activated partial thromboplastin time.showed that it shared 95.3–96.4% homology in nucleotide
sequence with strains isolated from other patients previously
reported in Zhejiang, indicating that they were from the same
origin (sequencing results have been submitted to GenBank,
accession numbers KP280204, KP280205, and KP280206;
Figure 1).
The case described here is that of an elderly female farmer who
lives in a mountainous region of Daishan County, Zhejiang
Province. She is engaged in agricultural activities in mountain
ﬁelds, which are usually infested by ticks. However, she had no
history of tick bites or skin damage before illness onset, and no
known exposure to persons with a similar illness in the area. She
had no underlying conditions or other infectious disease. She had
not traveled to other places for many years. Through a ﬁeld
epidemiological investigation and ecological survey, we found
that her living environment was unfavorable with rodents and
wild cats lingering around her house. Furthermore, we inter-
viewed her family members, neighboring villagers, and all
hospital staff who provided her with medical assistance, and
found no similar cases.
3. Discussion
We have described a special case of SFTSV infection, in which
the patient exhibited no fever during the entire process of the
disease. In addition, brain injury and an extended illness duration
(nearly 1 month) have rarely been reported before. There are two
possible reasons for this. Firstly, the exposure dose of SFTSV might
have been low. Secondly, the alteration of gene loci may have
affected virus binding and reduced its pathogenicity. Furthermore,
the patient recovered and no secondary SFTS cases were found in
any of her contacts. Could it be that the case’s virus transmissibility
was limited? It is unclear why the patient presented no fever.
Further research on the pathogenesis of human infection with
SFTSV is needed. Combined with the results of the epidemiological
investigation and evidence of possible person-to-person transmis-
sion of SFTSV infection,4,5 we cannot rule out the possibility of
occasional contact with ticks or other SFTS patients in this case. It is
also possible that this case was infected through some other
unknown transmission route.
The reported characteristics of this SFTSV case with no fever
provides meaningful insight into the early diagnosis and treatment
of patients, as well as the development of surveillance strategies
and preventive measures for SFTSV infection. In conclusion, it is
vital for clinical doctors to consider the patient’s clinicalrome (SFTS) in Zhejiang, China
Normal range
12 (Nov 1) 15 (Nov 4) 19 (Nov 8)
3.2 2.2 2.3 4–10
1.8 1.4 1.3 2–7.7
1.0 0.6 0.8 0.8–4
144 149 119 100–300
3.62 3.11 2.81 3.68–5.13
112 97 88 110–150
116 - 26 0–60
82 33 19 0–50
- 224 - 114–240
- 41 - 24–195
- 3 - 0–24
72 70 79 44–110
3.9 3.5 2.9 1.8–7.1
18.6 17.8 - 14.0–21.0
12.0 12.6 - 10.5–14.0
25.3 27.0 - 24–36
e; LDH, lactate dehydrogenase; CK, creatine kinase; BUN, blood urea nitrogen; TT,
Figure 1. Phylogenetic tree of the severe fever with thrombocytopenia syndrome virus (SFTSV) L-gene compared with other isolates.
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information together before drawing a conclusion regarding the
diagnosis. More attention should be paid to the diagnostic criteria
of SFTS.
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